KU Chow, WD Sommerlad, S Boehrer, B Schneider, G Seipelt, MJ Rummel, D Hoelzer, PS Mitrou, E Weidmann. Anti-CD20 antibody (IDEC-C2B8, rituximab) enhances efficacy of cytotoxic drugs on neoplastic lymphocytes in vitro: role of cytokines, complement, and caspases. Haematologica 2002;87(1):33-43; https://doi.org/10.3324/%x.